1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
2
|
El-Serag HB and Mason AC: Rising incidence
of hepatocellular carcinoma in the United States. N Engl J Med.
340:745–750. 1999. View Article : Google Scholar : PubMed/NCBI
|
3
|
Llovet JM, Bustamante J, Castells A,
Vilana R, Ayuso MC, Sala M, Brú C, Rodés J and Bruix J: Natural
history of untreated nonsurgical hepatocellular carcinoma:
Rationale for the design and evaluation of therapeutic trials.
Hepatology. 29:62–67. 1999. View Article : Google Scholar : PubMed/NCBI
|
4
|
Llovet JM, Fuster J and Bruix J:
Barcelona-Clínic Liver Cancer Group: The Barcelona approach:
Diagnosis, staging and treatment of hepatocellular carcinoma. Liver
Transpl. 10:(Suppl 1). S115–S120. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Llovet JM, Ricci S, Mazzaferro V, et al:
SHARP Investigators Study Group: Sorafenib in advanced
hepatocellular carcinoma. N Engl J Med. 359:378–390. 2008.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Cheng AL, Kang YK, Chen Z, et al: Efficacy
and safety of sorafenib in patients in the Asia-Pacific region with
advanced hepatocellular carcinoma: A phase III randomised,
double-blind, placebo-controlled trial. Lancet Oncol. 10:25–34.
2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Abou-Alfa GK, Schwartz L, Ricci S, et al:
Phase II study of sorafenib in patients with advanced
hepatocellular carcinoma. J Clin Oncol. 24:4293–4300. 2006.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Abou Alfa GK, Amadori D, Santoro A, et al:
Is sorafenib (S) safe and effective in patients (pts) with
hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis? J
Clin Oncol. 26:May 20;Suppl. 45182008.PubMed/NCBI
|
9
|
Hollebecque A, Cattan S, Romano O, et al:
Safety and efficacy of sorafenib in hepatocellular carcinoma: The
impact of the Child-Pugh score. Aliment Pharmacol Ther.
34:1193–1201. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Pressiani T, Boni C, Rimassa L, et al:
Sorafenib in patients with Child-Pugh class A and B advanced
hepatocellular carcinoma: A prospective feasibility analysis. Ann
Oncol. 24:406–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kim JE, Ryoo BY, Ryu MH, Chang HM, Suh DJ,
Lee HC, Lim YS, Kim KM and Kang YK: Sorafenib for hepatocellular
carcinoma according to Child-Pugh class of liver function. Cancer
Chemother Pharmacol. 68:1285–1290. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lencioni R, Kudo M, Ye SL, et al: First
interim analysis of the GIDEON (global investigation of therapeutic
decisions in hepatocellular carcinoma and of its treatment with
sorafenib) non-interventional study. Int J Clin Pract. 66:675–683.
2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Keating GM and Santoro A: Sorafenib: A
review of its use in advanced hepatocellular carcinoma. Drugs.
69:223–240. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Pinter M, Sieghart W, Graziadei I, Vogel
W, Maieron A, Königsberg R, Weissmann A, Kornek G, Plank C and
Peck-Radosavljevic M: Sorafenib in unresectable hepatocellular
carcinoma from mild to advanced stage liver cirrhosis. Oncologist.
14:70–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Iavarone M, Cabibbo G, Piscaglia F,
Zavaglia C, Grieco A, Villa E, Cammà C and Colombo M: SOFIA
(sorafenib Italian assessment) study group: Field-practice study of
sorafenib therapy for hepatocellular carcinoma: A prospective
multicenter study in Italy. Hepatology. 54:2055–2063. 2011.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Wörns MA, Weinmann A, Pfingst K, et al:
Safety and efficacy of sorafenib in patients with advanced
hepatocellular carcinoma in consideration of concomitant stage of
liver cirrhosis. J Clin Gastroenterol. 43:489–495. 2009. View Article : Google Scholar : PubMed/NCBI
|